Huapont Life Sciences Co Ltd (002004) - Total Assets
Based on the latest financial reports, Huapont Life Sciences Co Ltd (002004) holds total assets worth CN¥29.83 Billion CNY (≈ $4.37 Billion USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check 002004 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Huapont Life Sciences Co Ltd - Total Assets Trend (2001–2025)
This chart illustrates how Huapont Life Sciences Co Ltd's total assets have evolved over time, based on quarterly financial data. Explore Huapont Life Sciences Co Ltd (002004) investment intensity to see how much of total assets are deployed in long-term investments.
Huapont Life Sciences Co Ltd - Asset Composition Analysis
Current Asset Composition (December 2025)
Huapont Life Sciences Co Ltd's total assets of CN¥29.83 Billion consist of 39.5% current assets and 60.5% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 9.9% |
| Accounts Receivable | CN¥2.12 Billion | 7.3% |
| Inventory | CN¥2.02 Billion | 6.9% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥1.61 Billion | 5.5% |
| Goodwill | CN¥1.98 Billion | 6.8% |
Asset Composition Trend (2001–2025)
This chart illustrates how Huapont Life Sciences Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market cap of Huapont Life Sciences Co Ltd.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Huapont Life Sciences Co Ltd's current assets represent 39.5% of total assets in 2025, a decrease from 64.8% in 2001.
- Cash Position: Cash and equivalents constituted 9.9% of total assets in 2025, down from 17.3% in 2001.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 11.0% of total assets, an increase from 0.0% in 2001.
- Asset Diversification: The largest asset category is accounts receivable at 7.3% of total assets.
Huapont Life Sciences Co Ltd Competitors by Total Assets
Key competitors of Huapont Life Sciences Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Chambal Fertilizers & Chemicals Limited
NSE:CHAMBLFERT
|
India | Rs138.53 Billion |
|
Stanley Fertilizer Co Ltd
SHE:002588
|
China | CN¥15.67 Billion |
|
Kaveri Seed Company Limited
NSE:KSCL
|
India | Rs26.42 Billion |
|
Insecticides (India) Limited
NSE:INSECTICID
|
India | Rs19.97 Billion |
|
Boa Safra Sementes S.A
SA:SOJA3
|
Brazil | R$3.46 Billion |
|
Nongwoobio Co. Ltd
KQ:054050
|
Korea | ₩344.76 Billion |
|
Graines Voltz S.A
PA:GRVO
|
France | €168.49 Million |
|
Nusa Palapa Gemilang PT Tbk
JK:NPGF
|
Indonesia | Rp317.06 Billion |
Huapont Life Sciences Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.40 | 1.14 | 0.98 |
| Quick Ratio | 1.18 | 0.92 | 0.78 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥3.53 Billion | CN¥1.40 Billion | CN¥-225.70 Million |
Huapont Life Sciences Co Ltd - Advanced Valuation Insights
This section examines the relationship between Huapont Life Sciences Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.93 |
| Latest Market Cap to Assets Ratio | 0.04 |
| Asset Growth Rate (YoY) | -1.4% |
| Total Assets | CN¥29.03 Billion |
| Market Capitalization | $1.19 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Huapont Life Sciences Co Ltd's assets below their book value (0.04x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Huapont Life Sciences Co Ltd's assets decreased by 1.4% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Huapont Life Sciences Co Ltd (2001–2025)
The table below shows the annual total assets of Huapont Life Sciences Co Ltd from 2001 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥29.03 Billion ≈ $4.25 Billion |
-1.43% |
| 2024-12-31 | CN¥29.45 Billion ≈ $4.31 Billion |
-4.16% |
| 2023-12-31 | CN¥30.73 Billion ≈ $4.50 Billion |
+2.34% |
| 2022-12-31 | CN¥30.02 Billion ≈ $4.39 Billion |
-0.07% |
| 2021-12-31 | CN¥30.04 Billion ≈ $4.40 Billion |
+6.44% |
| 2020-12-31 | CN¥28.23 Billion ≈ $4.13 Billion |
+5.97% |
| 2019-12-31 | CN¥26.64 Billion ≈ $3.90 Billion |
+0.32% |
| 2018-12-31 | CN¥26.55 Billion ≈ $3.89 Billion |
-8.73% |
| 2017-12-31 | CN¥29.09 Billion ≈ $4.26 Billion |
+20.07% |
| 2016-12-31 | CN¥24.23 Billion ≈ $3.55 Billion |
+22.92% |
| 2015-12-31 | CN¥19.71 Billion ≈ $2.88 Billion |
+45.27% |
| 2014-12-31 | CN¥13.57 Billion ≈ $1.99 Billion |
+77.42% |
| 2013-12-31 | CN¥7.65 Billion ≈ $1.12 Billion |
+29.13% |
| 2012-12-31 | CN¥5.92 Billion ≈ $866.61 Million |
+41.36% |
| 2011-12-31 | CN¥4.19 Billion ≈ $613.04 Million |
+208.42% |
| 2010-12-31 | CN¥1.36 Billion ≈ $198.77 Million |
+18.84% |
| 2009-12-31 | CN¥1.14 Billion ≈ $167.26 Million |
+0.32% |
| 2008-12-31 | CN¥1.14 Billion ≈ $166.72 Million |
+4.66% |
| 2007-12-31 | CN¥1.09 Billion ≈ $159.30 Million |
+42.29% |
| 2006-12-31 | CN¥765.08 Million ≈ $111.96 Million |
+60.11% |
| 2005-12-31 | CN¥477.85 Million ≈ $69.92 Million |
-0.66% |
| 2004-12-31 | CN¥481.04 Million ≈ $70.39 Million |
+113.10% |
| 2003-12-31 | CN¥225.73 Million ≈ $33.03 Million |
+9.00% |
| 2002-12-31 | CN¥207.09 Million ≈ $30.30 Million |
+55.23% |
| 2001-12-31 | CN¥133.41 Million ≈ $19.52 Million |
-- |
About Huapont Life Sciences Co Ltd
Huapont Life Sciences Co.,Ltd. engages in the medicine, medical care, agrochemicals, new materials, tourism, and other businesses in China and internationally. The company is involved in the production and sale of pharmaceutical preparations and raw materials. It also offers medicines for skin, tuberculosis, anti-infection, respiratory, anti-tumor, and cardiovascular, as well as health management… Read more